ATG3 and non-small cell lung carcinoma: Research has shown that ATG3 is directly associated with the development of drug resistance, as the inhibition of ATG3-induced autophagy was able to promote salinomycin-induced apoptosis and enhance the cisplatin sensitivity in NSCLC (206, 207).